Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
Cells2021Vol. 10(7), pp. 1698–1698
Citations Over TimeTop 24% of 2021 papers
Yu‐Yun Shao, Nai-Yun Sun, Yung‐Ming Jeng, Yao‐Ming Wu, Chiun Hsu, Chih‐Hung Hsu, Hey-Chi Hsu, Ann‐Lii Cheng, Zhong-Zhe Lin
Abstract
High Eg5 expression was associated with poor HCC prognosis. In vitro and in vivo evidence suggests that Eg5 may be a reasonable therapeutic target for HCC.
Related Papers
- → Kinesin-Binding Protein Controls Microtubule Dynamics and Cargo Trafficking by Regulating Kinesin Motor Activity(2016)105 cited
- → Motor Reattachment Kinetics Play a Dominant Role in Multimotor-Driven Cargo Transport(2018)87 cited
- → The axonal transport motor kinesin‐2 navigates microtubule obstacles via protofilament switching(2017)38 cited
- → Kinesin Superfamily Proteins(2002)4 cited
- → Kinesin Superfamily Proteins(2008)2 cited